Published in Lab Business Week, January 14th, 2007
Recombinant DNA technologies launched the biotechnology industry by allowing cost-effective production of valuable therapeutic proteins in easily cultured and manipulated organisms. Despite the early success of biotechnology, protein expression of recombinant genes remains a key limiting step.
Efficient gene synthesis technology allows the complete redesign of any...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week